TEDxBoston - Dr Jay Bradner - Opensource Drug Discovery
Ғылым және технология
"ClC1=CC=C(C2=N[C@@H](CC(OC(C)(C)C)=O)C3=NN=C(C)N3C4=C2C(C)=C(C)S4)C=C1"
Dr. Jay Bradner Research Scientist and Instructor in Medicine at Harvard and Dana Farber Cancer Institute, shares his breakthrough approach for subverting the aggressive behavior of cancer by reprogramming a cell's fundamental identity . . . and he's giving the secrets away in order to spur open-source drug discovery.
In the spirit of ideas worth spreading, TEDx is a program of local, self-organized events that bring people together to share a TED-like experience. At a TEDx event, TEDTalks video and live speakers combine to spark deep discussion and connection in a small group. These local, self-organized events are branded TEDx, where x = independently organized TED event. The TED Conference provides general guidance for the TEDx program, but individual TEDx events are self-organized.* (*Subject to certain rules and regulations)
Пікірлер: 14
This is really incredible.
At, 6:54, "pet PET," that was super funny!
I'm wondering if a GPL-style patent license (or copyright for the compound information) could be written, enabling labs to release papers and information that anyone can work with, but mandating that all things that build off of it are released under the same license (just like GPL programming code). GPL-style licensing has created several successful commercial for-profit companies that make money from additional support and distribution surrounding the open source product.
That's great you work in drug discovery: thank you for your contributions. As you know better than me, drugs are temperature sensitive; how do you feel about big pharma shipping there medications in uncontrolled containers? For example, a chemotherapy pill which states not to exceed a certain temp.
Dr. Jay Bradner, now the president of Novartis Institutes for BioMedical Research. Kinda ironic...
What happened to this potential drug?
Nobel material! I called it...
He is now in big farmas pocket at Novartis...
Please Wake up , make profit or saving life
Simply releasing the molecule into the public domain may do more harm by making it unpatentable. How can pharma companies recoup their $1 billion costs.
@insertname5421
5 жыл бұрын
Open source didnt kill the software industry, it wont kill the pharma industry. Will it require a business model revision? For sure. But it wont kill them. Time to change big pharmas :)